Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04597749 · ClinicalTrials.gov registry record · NA
Nebula Study - Screener Apps and HSAT vs. PSG Comparison
A NA study, sponsored by ResMed.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04597749: Completed NA study, sponsored by ResMed.
NCT04597749 is a NA study that has completed, run by ResMed. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04597749, a NA study, has completed, sponsored by ResMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a prospective, unblinded, open-label, single group study. All subjects will undergo concurrent screener app, HSAT testing, and in-lab polysomnography.
Primary Outcome
The PSG clinical decision for treatment is defined as AHI≥15. Screener apps and HSATs provide AHI values that will be used for comparison.
Interventions
- DIAGNOSTIC_TEST PSG
- DIAGNOSTIC_TEST Home Sleep Apnea Test with FDA cleared devices
- OTHER Non-Contact Screening App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-10-27 |
| Est. Completion | 2021-01-20 |
| Phase | NA |
What the finished NCT04597749 record still lists
NCT04597749 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which PSG is the first listed.
NCT04597749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04597749 about?
NCT04597749 is a clinical study titled "Nebula Study - Screener Apps and HSAT vs. PSG Comparison". This is a prospective, unblinded, open-label, single group study. All subjects will undergo concurrent screener app, HSAT testing, and in-lab polysomnography.
What is the current status of trial NCT04597749?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2020-10-27. Estimated completion is 2021-01-20.
What interventions are being tested in trial NCT04597749?
The interventions under investigation include: PSG (DIAGNOSTIC_TEST), Home Sleep Apnea Test with FDA cleared devices (DIAGNOSTIC_TEST), Non-Contact Screening App (OTHER).
Who is sponsoring clinical trial NCT04597749?
This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04597749's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI